You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 267 No. 9, March 4, 1992 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Renin Predicts Diastolic Blood Pressure Response to Nonpharmacologic and Pharmacologic Therapy

M. Donald Blaufox, MD, PhD; Hyo Bok Lee, MS; Barry Davis, MD, PhD; Albert Oberman, MD; Sylvia Wassertheil-Smoller, PhD; Herbert Langford, MD

JAMA. 1992;267(9):1221-1225.


Abstract

Objective.
—Plasma renin activity was measured at baseline and 6 months in a trial of nonpharmacologic therapy of mild hypertension to determine whether plasma renin activity predicts the diastolic blood pressure (DBP) response to nonpharmacologic therapy.

Design, Setting, and Participants.
—Randomized controlled trial of volunteers from the general community with mild hypertension (DBP between 90 and 100 mm Hg), off all antihypertensive therapy at baseline, treated in special research clinics (n=593).

Interventions.
—Subjects were randomly assigned to usual, weight loss, or low sodium/high potassium diet and then randomly assigned to receive placebo, chlorthalidone, or atenolol.

Main Outcome Measures.
—Renin was analyzed as plasma renin activity and as a renin index (logarithm of 24-hour urinary sodium excretion times logarithm of plasma renin activity) (593 patients at baseline and 6 months) to correct for varied sodium intakes. The DBP was measured using the random zero device.

Results.
—Change in DBP at 6 months could be predicted from baseline plasma renin activity or renin index. The DBP was decreased after 6 months of therapy by 2 mm Hg for each unit increase in baseline plasma renin activity and by 0.16 mm Hg for each unit increase in baseline renin index. Patients in the highest renin index quartile had a greater DBP response to atenolol therapy, and patients in the lowest renin index quartile had a greater DBP response to chlorthalidone therapy. Weight loss diet achieved a greater reduction in DBP in patients with higher baseline renin index and had an additive effect on DBP response in both of the drug groups. Patients on a weight loss diet receiving placebo in the highest baseline renin index quartile had a reduction in DBP of 12.4 mm Hg, compared with 4.4 mm Hg in the lowest baseline renin index quartile (P=.009). A low sodium/high potassium diet had a lesser effect than a weight loss diet on pharmacologic therapy. As with the weight loss diet, patients on a low sodium/high potassium diet in the highest baseline renin index quartile had a greater reduction in DBP than patients in the lowest baseline renin index quartile.

Conclusions.
—These data suggest a significant relationship between baseline levels of plasma renin index and the likelihood of success of nonpharmacologic treatment of hypertension.

(JAMA. 1992;267:1221-1225)



Author Affiliations

From the Departments of Nuclear Medicine (Dr Blaufox and Ms Lee), Medicine (Dr Blaufox), and Epidemiology and Social Medicine (Dr Wassertheil-Smoller), Albert Einstein College of Medicine, Bronx, NY; the Coordinating Center for Clinical Trials, School of Public Health, University of Texas Health Science Center, Houston (Dr Davis); the Division of General and Preventive Medicine, Department of Medicine, University of Alabama Medical Center, Birmingham (Dr Oberman); and the Division of Endocrinology and Hypertension, Department of Medicine, University of Mississippi Medical Center, Jackson (Dr Langford).


Footnotes

Deceased.

Reprint requests to Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461 (Dr Blaufox).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Long-term Effects of Weight-Reducing Interventions in Hypertensive Patients: Systematic Review and Meta-analysis
Horvath et al.
Arch Intern Med 2008;168:571-580.
ABSTRACT | FULL TEXT  

Weight Loss and the Renin-Angiotensin-Aldosterone System
Engeli et al.
Hypertension 2005;45:356-362.
ABSTRACT | FULL TEXT  

Hypertension and the Vascular Patient
Samson
VASC ENDOVASCULAR SURG 2004;38:103-119.
ABSTRACT  

Can Renin Status Predict the Antihypertensive Efficacy of Eplerenone Add-On Therapy?
Prisant et al.
J Clin Pharmacol 2003;43:1203-1210.
ABSTRACT | FULL TEXT  

Renin Profiling to Predict Response to Antihypertensive Therapy
Blaufox et al.
JAMA 1999;281:793-794.
FULL TEXT  

Food Restriction Reduces Sympathetic Support of Blood Pressure in Spontaneously Hypertensive Rats
Overton et al.
J. Nutr. 1997;127:655-660.
ABSTRACT | FULL TEXT  

Reduction in Long-term Antihypertensive Medication Requirements: Effects of Weight Reduction by Dietary Intervention in Overweight Persons With Mild Hypertension
Davis et al.
Arch Intern Med 1993;153:1773-1782.
ABSTRACT  

COMPARING NONDRUG THERAPIES FOR HYPERTENSION
JWatch General 1992;1992:2-2.
FULL TEXT  

Predicting the Response to Nonpharmacologic Treatment in Mild Hypertension
Pickering
JAMA 1992;267:1256-1257.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.